DK0817637T3 - Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC - Google Patents

Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC

Info

Publication number
DK0817637T3
DK0817637T3 DK96911953T DK96911953T DK0817637T3 DK 0817637 T3 DK0817637 T3 DK 0817637T3 DK 96911953 T DK96911953 T DK 96911953T DK 96911953 T DK96911953 T DK 96911953T DK 0817637 T3 DK0817637 T3 DK 0817637T3
Authority
DK
Denmark
Prior art keywords
ftc
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
DK96911953T
Other languages
English (en)
Inventor
Clair Martha Heider St
David Walter Barry
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0817637(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0817637T3 publication Critical patent/DK0817637T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cephalosporin Compounds (AREA)
DK96911953T 1995-03-30 1996-03-28 Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC DK0817637T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (1)

Publication Number Publication Date
DK0817637T3 true DK0817637T3 (da) 2002-11-11

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96911953T DK0817637T3 (da) 1995-03-30 1996-03-28 Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC

Country Status (36)

Country Link
US (1) US6417191B1 (da)
EP (1) EP0817637B1 (da)
JP (1) JP2954357B2 (da)
KR (1) KR100542536B1 (da)
CN (1) CN1103593C (da)
AP (1) AP652A (da)
AT (1) ATE220551T1 (da)
AU (1) AU715213B2 (da)
BR (3) BRPI9607851B8 (da)
CA (1) CA2216634C (da)
CZ (1) CZ295940B6 (da)
DE (3) DE69622386T2 (da)
DK (1) DK0817637T3 (da)
EA (1) EA000626B3 (da)
EE (1) EE04047B1 (da)
ES (1) ES2179193T3 (da)
FR (1) FR05C0022I2 (da)
GE (1) GEP20022647B (da)
HK (1) HK1009401A1 (da)
HU (1) HU224010B1 (da)
IL (1) IL117727A (da)
LU (1) LU91171I2 (da)
MX (1) MX9707316A (da)
MY (1) MY115461A (da)
NL (1) NL300195I2 (da)
NO (2) NO313787B1 (da)
NZ (1) NZ306419A (da)
OA (1) OA10616A (da)
PL (1) PL187085B1 (da)
PT (1) PT817637E (da)
RO (1) RO117995B1 (da)
SI (1) SI0817637T1 (da)
SK (1) SK283825B6 (da)
TR (1) TR199701074T1 (da)
UA (1) UA60293C2 (da)
WO (1) WO1996030025A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1228026A (zh) * 1996-06-25 1999-09-08 葛兰素集团有限公司 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
BR9809127A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
US20060246130A1 (en) 2003-01-14 2006-11-02 Dahl Terrence C Compositions and methods for combination antiviral therapy
WO2004085406A1 (en) 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Benzyl-pyridazinons as reverse transcriptase inhibitors
JP4931593B2 (ja) 2003-10-24 2012-05-16 イミュネイド ピーティーワイ リミテッド 治療の方法
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
AU2006303368B2 (en) 2005-10-19 2011-05-26 F. Hoffmann-La Roche Ag Non-Nucleoside Reverse Transcriptase Inhibitors
BRPI0720436A2 (pt) 2006-12-13 2014-01-07 Hoffmann La Roche Inibidores de transcriptase reversa de não-nucleosídeo
PT2120878E (pt) * 2007-02-09 2014-11-05 Alphapharm Pty Ltd Forma farmacêutica contendo duas ou mais substancias ativas em diferentes formas físicas
PT2435825E (pt) 2009-05-27 2015-11-02 Biotempus Ltd Métodos para o tratamento de doenças
ES2670811T3 (es) 2010-01-27 2018-06-01 Viiv Healthcare Company Terapia antivírica
CA2918707A1 (en) 2013-08-29 2015-03-05 Teva Pharmaceuticals Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
TW201622731A (zh) 2014-04-08 2016-07-01 泰瓦藥品工業有限公司 包含恩曲他濱（Ｅｍｔｒｉｃｉｔａｂｉｎｅ）、替諾福韋（Ｔｅｎｏｆｏｖｉｒ）、地瑞那韋（Ｄａｒｕｎａｖｉｒ）及利托那韋（Ｒｉｔｏｎａｖｉｒ）之單位劑型以及包含地瑞那韋及利托那韋之單層錠劑
EP3180349A4 (en) 2014-08-12 2018-08-22 Monash University Lymph directing prodrugs
WO2017041139A1 (en) 2015-09-08 2017-03-16 Monash University Lymph directing prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
WO2019046491A1 (en) * 2017-08-29 2019-03-07 Ariya Therapeutics, Inc. LIPIDIC PRODRUGS DIRECTING TO THE LYMPHATIC SYSTEM
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
EP4100017A4 (en) 2020-02-05 2024-04-10 Puretech Lyt Inc LIPID PRODRUGS OF NEUROSTEROIDS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
SK279262B6 (sk) 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je
WO1993023021A2 (en) * 1992-05-13 1993-11-25 The Wellcome Foundation Limited Therapeutic combinations
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
IL127350A0 (en) 1996-06-25 1999-10-28 Glaxo Group Ltd Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
CN1228026A (zh) 1996-06-25 1999-09-08 葛兰素集团有限公司 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
LU91171I9 (da) 2018-12-28
JPH10511682A (ja) 1998-11-10
EP0817637B1 (en) 2002-07-17
HU224010B1 (hu) 2005-04-28
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
NO2005014I2 (no) 2008-02-11
AU5497296A (en) 1996-10-16
DE122005000029I1 (de) 2005-10-06
EA000626B3 (ru) 2016-04-29
EP0817637A1 (en) 1998-01-14
AU715213B2 (en) 2000-01-20
CA2216634A1 (en) 1996-10-03
IL117727A (en) 1999-11-30
NO313787B1 (no) 2002-12-02
BRPI9612992B1 (pt) 2020-08-04
AP652A (en) 1998-06-19
NO974510L (no) 1997-09-29
MY115461A (en) 2003-06-30
EE9700240A (et) 1998-04-15
CA2216634C (en) 2004-07-20
HUP9801571A3 (en) 2001-04-28
MX9707316A (es) 1997-11-29
DE69622386T2 (de) 2003-02-13
SK129597A3 (en) 1998-07-08
PL187085B1 (pl) 2004-05-31
RO117995B1 (ro) 2002-12-30
CZ309097A3 (cs) 1998-05-13
NL300195I2 (nl) 2005-11-01
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
ATE220551T1 (de) 2002-08-15
CN1185110A (zh) 1998-06-17
ES2179193T3 (es) 2003-01-16
EE04047B1 (et) 2003-06-16
OA10616A (en) 2001-03-15
HK1009401A1 (en) 1999-09-10
BRPI9607851B8 (pt) 2019-11-05
FR05C0022I2 (da) 2005-10-21
EA199700203A1 (ru) 1998-02-26
AP9701089A0 (en) 1997-10-31
GEP20022647B (en) 2002-03-25
FR05C0022I1 (da) 2005-06-10
KR100542536B1 (ko) 2006-03-23
KR19980703420A (ko) 1998-11-05
BR9607851A (pt) 1998-07-21
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (en) 1996-10-03
JP2954357B2 (ja) 1999-09-27
NO974510D0 (no) 1997-09-29
DE122005000029I2 (de) 2006-04-27
CZ295940B6 (cs) 2005-12-14
IL117727A0 (en) 1996-07-23
SI0817637T1 (en) 2002-10-31
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
BR9607851B1 (pt) 2009-01-13
CN1103593C (zh) 2003-03-26
LU91171I2 (fr) 2005-07-04
NO2005014I1 (no) 2005-06-06
PL322532A1 (en) 1998-02-02
US6417191B1 (en) 2002-07-09
EA000626B1 (ru) 1999-12-29
UA60293C2 (uk) 2003-10-15

Similar Documents

Publication Publication Date Title
DK0817637T3 (da) Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
NO972983D0 (no) Sulfonamider og deres anvendelse
NO964583D0 (no) Lettvekts brönnsementsammensetninger og fremgangsmåter
DK0871656T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO20006488D0 (no) Sammensetning og anvendelse
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO981282D0 (no) Calcitriolderivater og deres anvendelser
NO986034D0 (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse
NO952575D0 (no) Flytende vanillinblanding, deres fremstilling og anvendelse
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
NO963723L (no) Flytepunktnedsettende tilsetningsstoffer og deres anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK278289A (da) Ekspressionsvektorer, deres fremstilling og anvendelse til fremstilling af ufusionerede proteiner i mikroorganismer
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse
NO986035D0 (no) Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse
NO982242D0 (no) Heparinanaloge kopolymerer, deres fremstilling og anvendelse
PT101949A (pt) Boneco com elevacao simultania de bracos, pernas e abertura de olhos